[Treatment of osteoporosis from the socioeconomic perspectives].
Health economic evaluation for osteoporosis suffers from methodological limitations. For example, osteoporosis results in various types of fractures each with different impact on patients. Another example is that some therapeutic drugs have extraskeletal benefits and adverse events. Osteoporosis and resultant fracture has profound effects on patients' life expectancy and quality of life, which, however, is not well understood. To promote the health economic evaluation for osteoporosis is our urgent research project in Japan.
Tanaka
Kiyoshi
K
Kyoto Women's University, Department of Food and Nutrition.
D050071:Bone Density Conservation Agents; D003362:Cost-Benefit Analysis / Q000379:methods*; D004164:Diphosphonates; D005265:Femoral Neck Fractures / Q000209:etiology / Q000517:prevention & control; D017048:Health Care Costs; D006801:Humans; D007564:Japan; D018803:Models, Economic; D010024:Osteoporosis / Q000150:complications / Q000628:therapy*; D020845:Selective Estrogen Receptor Modulators
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators